Showing 19,821 - 19,840 results of 103,727 for search '(( 2 step decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.05s Refine Results
  1. 19821

    A New Approach to the Photochemically Controlled Crown Ethers: (Tetramethylcyclobutadiene)cobalt Complexes with Benzo-15-Crown-5 and Dibenzo-18-Crown-6 by Dmitry S. Perekalin (2412760)

    Published 2008
    “…The sodium-binding ability of cobalt complexes <b>2</b>, <b>4</b>, and <b>5</b> (determined by NMR titration; <i>K</i><sub>a</sub> = 2500, 800, and 50, respectively) was found to be much smaller than that of the free crown ethers <b>1</b> and <b>3</b> (<i>K</i><sub>a</sub> = 200 000 and 5 000 000). …”
  2. 19822

    A New Approach to the Photochemically Controlled Crown Ethers: (Tetramethylcyclobutadiene)cobalt Complexes with Benzo-15-Crown-5 and Dibenzo-18-Crown-6 by Dmitry S. Perekalin (2412760)

    Published 2008
    “…The sodium-binding ability of cobalt complexes <b>2</b>, <b>4</b>, and <b>5</b> (determined by NMR titration; <i>K</i><sub>a</sub> = 2500, 800, and 50, respectively) was found to be much smaller than that of the free crown ethers <b>1</b> and <b>3</b> (<i>K</i><sub>a</sub> = 200 000 and 5 000 000). …”
  3. 19823
  4. 19824
  5. 19825
  6. 19826
  7. 19827

    DataSheet_1_Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report.pdf by Ruiqi Niu (2362630)

    Published 2024
    “…PFS was 4.5 months. When follow up imaging showed lesions progression, the white blood cell count increased again, diagnosing a paraneoplastic leukemic reaction. …”
  8. 19828

    BjussuLAAO-II induces cytotoxicity and alters DNA methylation of cell-cycle genes in monocultured/co-cultured HepG2 cells by Ana Rita Thomazela Machado (6047777)

    Published 2019
    “…In co-culture, 1.00 and 5.00 μg/mL induced cytotoxicity (p < 0.05). BjussuLAAO-II increased the methylation of CCND1 and decreased the methylation of CDKN1A in monoculture and GADD45A in both cell-culture models (p < 0.05). …”
  9. 19829
  10. 19830

    Image_5_Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.tif by Thabatta L. S. A. Rosa (11195667)

    Published 2021
    “…Inhibition of M. leprae 3β-HSD activity with the 17β-[N-(2,5-di-t-butylphenyl)carbamoyl]-6-azaandrost-4-en-3one (compound 1), decreased bacterial intracellular survival in SCs. …”
  11. 19831

    Image_5_Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.tif by Thabatta L. S. A. Rosa (11195667)

    Published 2021
    “…Inhibition of M. leprae 3β-HSD activity with the 17β-[N-(2,5-di-t-butylphenyl)carbamoyl]-6-azaandrost-4-en-3one (compound 1), decreased bacterial intracellular survival in SCs. …”
  12. 19832
  13. 19833
  14. 19834
  15. 19835

    Table_5_The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical Studies.DOC by Yuquan Rao (9118304)

    Published 2020
    “…Exclusion criteria included adult studies; duplicate publications; management with dexmedetomidine alone; review or meta-analysis; basic research; article published as abstract, letter, case report, editorial, note, method, or protocol; and article presented in non-English language.</p><p>Results: Fifty-eight randomized controlled trials (RCTs) and five case-control trials (CCTs) including 7,714 patients were included. …”
  16. 19836
  17. 19837

    Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study by Yukimi Otsuka (5142788)

    Published 2018
    “…Our study suggests that TCZ decreases the HbA1c levels in RA patients to a greater extent than TNFi.…”
  18. 19838
  19. 19839

    Image_2_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tiff by Renato Simões Gaspar (8384040)

    Published 2020
    “…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”
  20. 19840